Anti-viral guanine compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544244, 544276, 544277, C07D47318, A61K 3152

Patent

active

048164470

ABSTRACT:
9-(1,3-Dihydroxy-2-propoxymethyl)guanine and 9-(2,3-dihydroxy-1-propoxymethyl)guanine have been found to have potent anti-viral activity against herpes viruses. These compounds, their acyl derivatives, their phosphate derivatives and their pharmaceutically acceptable salts, pharmaceutical formulations containing these compounds, the treatment of DNA viral or herpes viral infections with these compounds, method of preparing these compounds, and novel intermediates useful in their preparation are all disclosed.
The compounds may be prepared by reaction of the appropriate acetoxymethyl ether with diacetylguanine, followed by deprotection. The acetoxymethyl ethers may be obtained by reaction of glycerol formal with acetic anhydride in the presence of a catalyst.

REFERENCES:
patent: 4199574 (1980-04-01), Schaeffer
patent: 4287188 (1981-09-01), Schaeffer
patent: 4590269 (1986-05-01), Onisbe et al.
patent: 4603219 (1986-07-01), Verheyden et al.
patent: 4670424 (1987-06-01), Mac Ross et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anti-viral guanine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-viral guanine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-viral guanine compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1659322

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.